Your browser doesn't support javascript.
loading
Correction: IGF-1 and hyperglycaemia-induced FOXA1 and IGFBP-2 affect epithelial to mesenchymal transition in prostate epithelial cells.
Mansor, Rehanna; Holly, Jeff; Barker, Rachel; Biernacka, Kalina; Zielinska, Hanna; Koupparis, Anthony; Rowe, Edward; Oxley, Jon; Sewell, Alex; Martin, Richard M; Lane, Athene; Hackshaw-McGeagh, Lucy; Perks, Claire.
Affiliation
  • Mansor R; IGFs and Metabolic Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK.
  • Holly J; Faculty of Medicine, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, MY.
  • Barker R; IGFs and Metabolic Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK.
  • Biernacka K; IGFs and Metabolic Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK.
  • Zielinska H; IGFs and Metabolic Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK.
  • Koupparis A; IGFs and Metabolic Endocrinology Group, Bristol Medical School, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK.
  • Rowe E; Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol, UK.
  • Oxley J; Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol, UK.
  • Sewell A; Department of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
  • Martin RM; Department of Cellular Pathology, North Bristol NHS Trust, Southmead Hospital, Bristol, UK.
  • Lane A; NIHR Biomedical Research Centre, Level 3, University Hospitals Bristol Education Centre, Bristol, UK.
  • Hackshaw-McGeagh L; Population Health Sciences, University of Bristol, Bristol, UK.
  • Perks C; NIHR Biomedical Research Centre, Level 3, University Hospitals Bristol Education Centre, Bristol, UK.
Oncotarget ; 14: 44-46, 2023 Jan 26.
Article in En | MEDLINE | ID: mdl-36702334
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2023 Document type: Article Affiliation country: Country of publication: